[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2006/136402,2006,A1Locationinpatent:Page/Pagecolumn80
[2]Locationinpatent:schemeortableKortum,StevenW.;Lachance,RhondaM.;Schweitzer,BarbaraA.;Yalamanchili,Gopichand;Rahman,Hayat;Ennis,MichaelD.;Huff,RitaM.;TenBrink,RuthE.[BioorganicandMedicinalChemistryLetters,2009,vol.19,#20,p.5919-5923]
[3]Phoujdar,ManishaS.;Kathiravan,MuthuK.;Bariwal,JitenderB.;Shah,AnamikK.;Jain,KishorS.[TetrahedronLetters,2008,vol.49,#7,p.1269-1273]
[4]Ostrynska,OlgaV.;Balanda,AnatoliyO.;Bdzhola,VolodymyrG.;Golub,AndriyG.;Kotey,IgorM.;Kukharenko,OlexanderP.;Gryshchenko,AndriiA.;Briukhovetska,NadiiaV.;Yarmoluk,SergiyM.[EuropeanJournalofMedicinalChemistry,2016,vol.115,p.148-160]
[5]Ram;Pandey;Vlietinck[JournalofHeterocyclicChemistry,1981,vol.18,#7,p.1277-1280]
[6]Locationinpatent:schemeortableHoriuchi,Takao;Chiba,Jun;Uoto,Kouichi;Soga,Tsunehiko[BioorganicandMedicinalChemistryLetters,2009,vol.19,#2,p.305-308]
[1]CurrentPatentAssignee:ABBVIEINC-US6232320,2001,B1
[1]Lettersindrugdesignanddiscovery,2018,vol.15,p.463-474
[1]Yong,Jianping;Lu,Canzhong;Wu,Xiaoyuan[Lettersindrugdesignanddiscovery,2018,vol.15,#5,p.463-474]
[1]Yong,Jianping;Lu,Canzhong;Wu,Xiaoyuan[Lettersindrugdesignanddiscovery,2018,vol.15,#5,p.463-474]
Title: Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Journal: Nature chemical biology 20120129